Table 1.

Characteristics of CCG 2891 de novo patients



White

Black

Hispanic

Asian

No.
%
P
No.
%
P
No.
%
P
No.
%
P
Total   558   70.5   NA   94   11.9   NA   114   14.4   NA   25   3.2   NA  
Age, y   7.8   NA   .677   7.5   NA   .756   7.9   NA   .478   11.0   NA   .436  
Male   282   50.5   .617   42   44.7   .348   70   61.4   .044   11   44.0   .663  
WBC count   22.7   NA   .632   25.8   NA   .844   20.4   NA   .485   18.8   NA   .613  
CNS disease   53   9.5   .207   5   5.3   .262   6   5.3   .203   4   16.0   .467  
Induction timing             
INT   351   62.9   .316   50   53.2   .094   71   62.3   .985   16   64.0   .920  
STD   196   35.1   .191   44   46.8   .040   41   36.0   .949   9   36.0   .901  
STD/INT   11   2.0   .365   0   0.0   .380   2   1.8   1.000   0   0.0   >.999  
Cytogenetics             
Normal   80   25.7   .902   11   20.8   .548   11   28.2   .889   3   60.0   .116  
t(8;21)   35   11.3   .235   7   13.2   .858   8   20.5   .117   1   20.0   .456  
Abn. 16   28   9.0   .317   4   7.5   >.999   1   2.6   .227   0   0.0   >.999  
Abn. 11   64   20.6   .009   4   7.5   .022   4   10.3   .186   0   0.0   .587  
t(6;9)   3   1.0   .341   1   1.9   .469   1   2.6   .378   0   0.0   >.999  
−7/7q-   12   3.9   .394   3   5.7   .466   3   7.7   .227   0   0.0   >.999  
−5/5q-   4   1.3   .364   2   3.8   .212   1   2.6   .448   0   0.0   >.999  
Trisomy 8   21   6.8   .119   6   11.3   .255   5   12.8   .190   1   20.0   .305  
Trisomy 21   7   2.3   .686   1   1.9   >.999   0   0.0   1.000   0   0.0   >.999  
Other   57   18.3   .897   14   26.4   .236   5   12.8   .531   0   0.0   .590  
No data
 
247
 
NA
 
NA
 
41
 
NA
 
NA
 
75
 
NA
 
NA
 
20
 
NA
 
NA
 


White

Black

Hispanic

Asian

No.
%
P
No.
%
P
No.
%
P
No.
%
P
Total   558   70.5   NA   94   11.9   NA   114   14.4   NA   25   3.2   NA  
Age, y   7.8   NA   .677   7.5   NA   .756   7.9   NA   .478   11.0   NA   .436  
Male   282   50.5   .617   42   44.7   .348   70   61.4   .044   11   44.0   .663  
WBC count   22.7   NA   .632   25.8   NA   .844   20.4   NA   .485   18.8   NA   .613  
CNS disease   53   9.5   .207   5   5.3   .262   6   5.3   .203   4   16.0   .467  
Induction timing             
INT   351   62.9   .316   50   53.2   .094   71   62.3   .985   16   64.0   .920  
STD   196   35.1   .191   44   46.8   .040   41   36.0   .949   9   36.0   .901  
STD/INT   11   2.0   .365   0   0.0   .380   2   1.8   1.000   0   0.0   >.999  
Cytogenetics             
Normal   80   25.7   .902   11   20.8   .548   11   28.2   .889   3   60.0   .116  
t(8;21)   35   11.3   .235   7   13.2   .858   8   20.5   .117   1   20.0   .456  
Abn. 16   28   9.0   .317   4   7.5   >.999   1   2.6   .227   0   0.0   >.999  
Abn. 11   64   20.6   .009   4   7.5   .022   4   10.3   .186   0   0.0   .587  
t(6;9)   3   1.0   .341   1   1.9   .469   1   2.6   .378   0   0.0   >.999  
−7/7q-   12   3.9   .394   3   5.7   .466   3   7.7   .227   0   0.0   >.999  
−5/5q-   4   1.3   .364   2   3.8   .212   1   2.6   .448   0   0.0   >.999  
Trisomy 8   21   6.8   .119   6   11.3   .255   5   12.8   .190   1   20.0   .305  
Trisomy 21   7   2.3   .686   1   1.9   >.999   0   0.0   1.000   0   0.0   >.999  
Other   57   18.3   .897   14   26.4   .236   5   12.8   .531   0   0.0   .590  
No data
 
247
 
NA
 
NA
 
41
 
NA
 
NA
 
75
 
NA
 
NA
 
20
 
NA
 
NA
 

Median values reported for age and WBC count. For statistical analysis, white patients were compared with a combined ethnic group, and other ethnic groups were individually compared with white patients alone.

INT indicates intensive timing; STD, standard timing; STD/INT, combination intensive and standard timing; and NA, not applicable.

or Create an Account

Close Modal
Close Modal